Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DR6E | ISIN: CA60255C8850 | Ticker-Symbol: MMQ
Tradegate
05.11.24
14:43 Uhr
5,610 Euro
+0,040
+0,72 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
MIND MEDICINE MINDMED INC Chart 1 Jahr
5-Tage-Chart
MIND MEDICINE MINDMED INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,3805,58516:28
5,4205,53516:28

Aktuelle News zur MIND MEDICINE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
24.10.Mind Medicine Inc.: MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update177Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced...
► Artikel lesen
18.10.MindMed announces exchange agreement with investors15
17.10.Mind Medicine Inc. - 8-K, Current Report2
26.09.Carrie Liao Sells 2,352 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock16
26.09.Mind Medicine's chief medical officer sells shares worth over $41,0005
26.09.MindMed executive sells over $26k in company stock3
26.09.MindMed CEO Robert Barrow sells shares worth over $118,0009
26.09.MindMed executive sells shares worth over $14k12
16.09.MindMed stock target trimmed, rating retained on dilution concerns8
16.09.Kursziel für MindMed-Aktie gesenkt, Kaufempfehlung trotz Verwässerungsbedenken beibehalten13
09.09.Mind Medicine Inc.: MindMed Announces New Employee Inducement Grants366Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced...
► Artikel lesen
04.09.Mind Medicine Inc.: MindMed to Participate in September Investor Conferences202Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced...
► Artikel lesen
21.08.Mind Medicine CEO Robert Barrow buys $6,215 in shares16
13.08.Mind Medicine Inc. - 10-Q, Quarterly Report6
13.08.Mind Medicine Inc.: MindMed Reports Second Quarter 2024 Financial Results and Business Updates442--Completed End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA); on track to initiate Phase 3 clinical program for MM120 orally disintegrating tablet (ODT) in Generalized...
► Artikel lesen
13.08.MindMed Reports Second Quarter 2024 Financial Results and Business Updates116NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain...
► Artikel lesen
12.08.Psychedelics Company MindMed Prices Public Offering Aiming To Raise $75M8
12.08.Mind Medicine Q2 2024 Earnings Preview4
12.08.Mind Medicine Inc. - 8-K, Current Report3
09.08.MindMed announces mega-million public offering15
Seite:  Weiter >>
56 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1